Azimilide decreases recurrent ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators - Azimilide and Recurrent VT in Patients With ICDs


The goal of the trial was to evaluate the effect of azimilide dihydrochloride, a novel antiarrhythmic, on the recurrence of implantable cardioverter defibrillator (ICD) therapies (shocks and antitachycardia pacing [ATP]) in patients with documented ventricular tachycardia (VT) who had an ICD.